Dosed ingredient Cosmetic cross-reference

Gluconolactone

CAS 90-80-2

Gluconolactone (CAS 90-80-2) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Gluconolactone

CAS Number

90-80-2

UNII

WQ29KQ9POT

InChIKey

PHOQVHQSTUBQQK-SQOUGZDYSA-N

ChEMBL ID

CHEMBL1200829

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

dosed ingredientnatural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)

Approved or marketed human pharmaceutical use is represented in the source phase field.

ChEMBL CHEMBL1200829 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 5 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	IC50	19976.309999999998 nM	1	-
-	AC50	1258.9 nM	1	-
-	Ki	30000 nM	1	-
-	Potency	794.3 nM	1	-
Glucosylceramidase Enzyme	Ki	4.52	-	Homo sapiens

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
GLUCONOLACTONE	25842	SU	MTHSPL
Gluconolactone	25842	SU	MTHSPL
gluconolactone	25842	SU	MTHSPL
gluconolactone	25842	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Gluconolactone used for in pharmaceutical contexts?

Gluconolactone (CAS 90-80-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Gluconolactone?

No adverse-event association or SIDER side-effect rows are rendered for Gluconolactone in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Gluconolactone also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Gluconolactone with EU status "permitted".

What clinical phase is Gluconolactone in?

Gluconolactone is rendered with ChEMBL max phase 4 (approved).

What bioactivity targets are documented for Gluconolactone?

Gluconolactone has 5 bioactivity rows in this page query. Rendered target entries include Glucosylceramidase.